Therapy News and Research

RSS

Researchers investigate new treatment that is effective against recurrent breast cancers

What do one in five breast cancers have in common? Large amounts of a protein called HER2 (or human epidermal growth factor receptor 2).

30 Jul 2018

Researchers discover various mechanisms of resistance to cancer therapy

An international research team under the co-direction of the University of Bern and the Netherlands Cancer Institute has discovered various mechanisms of resistance to cancer therapy. The findings help researchers to understand the self-repair of cancer cells after a therapy and thus help to fight resistant tumours more efficiently.

30 Jul 2018

Researchers discover how breast cells prevent cancer invasion

Researchers have shown that the cell layer surrounding breast milk ducts reaches out and engulfs cancerous cells to stop their spread.

30 Jul 2018

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended broadening the existing marketing authorization for Darzalex® for use as frontline therapy.

28 Jul 2018

QUT researchers conclude that men do suffer from Postcoital Dysphoria

A world-first study by QUT researchers concludes men can and do suffer from Postcoital Dysphoria which results in feelings of sadness, tearfulness or irritability following sex.

28 Jul 2018

New study aims to develop nucleoside therapy as treatment for mitochondrial depletion syndromes

Hundreds of types of mitochondrial disease affect up to 38 million people worldwide, yet there are very few effective treatments, forcing patients and doctors to rely on symptom management to battle the serious and potentially fatal genetic disorder that starves the body’s cells of energy.

27 Jul 2018

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

On July 25, the radiation oncology department at Tübingen University Hospital introduced its new Elekta Unity MR-linac, a groundbreaking cancer treatment system that integrates two critical but distinct technologies in a single platform: a state-of-the-art, high field wide bore 1.5 Tesla MR imaging system and a next-generation linear accelerator.

27 Jul 2018

Pairing online patient dashboard with 'nudges' to doctors triples statin prescribing rates

Pairing an online patient dashboard with "nudges" to doctors tripled statin prescribing rates in a clinical trial led by Penn Medicine researchers.

27 Jul 2018

New UCI center seeks to empower patients, providers through use of AI in healthcare

Physicians at the University of California, Irvine and UCI Health System have launched the UCI Center for Artificial Intelligence in Diagnostic Medicine, which seeks to advance patient care, improve health outcomes and lower costs by leveraging machine learning technology in all areas of healthcare.

27 Jul 2018

OHSU researchers discover disease in monkeys that mimics childhood neurodegenerative disorder

OHSU scientists have discovered a naturally occurring disease in monkeys that mimics a deadly childhood neurodegenerative disorder in people - a finding that holds promise for developing new gene therapies to treat Batten disease.

27 Jul 2018

Cannabis appears to have no effect on breathlessness during exercise in advanced COPD patients

Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease, according to a randomized controlled trial published online in the Annals of the American Thoracic Society.

27 Jul 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Alnylam’s patisiran receives positive opinion from CHMP for treating hATTR amyloidosis

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Committee for Medicinal Products for Human Use has adopted a Positive Opinion recommending marketing authorization of patisiran for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

27 Jul 2018

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

An estimated 2.3 million people globally are infected with both human immunodeficiency virus type 1 and hepatitis C virus.

27 Jul 2018

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

UCSF Benioff Children's Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.

27 Jul 2018

Newer version of ALS drug may effectively treat inherited form of the disease

NIH-funded researchers delayed signs of amyotrophic lateral sclerosis in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1.

27 Jul 2018

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

Researchers have helped solve a decades-old mystery about which mutations are responsible for an inherited bone marrow disorder.

27 Jul 2018

Scientists take important step to understand mechanisms that cause Huntington's disease

The neuroscientist Dr David Vilchez and his team at CECAD, the University of Cologne's Cluster of Excellence for Aging Research, have made an important step towards understanding the mechanisms that cause the neurodegenerative disorder Huntington's disease.

27 Jul 2018

Mind-body therapies provide promising approach to tackle teen anxiety

Mind-body therapies – biofeedback, mindfulness, yoga, and hypnosis – provide a promising approach to the very common problem of anxiety in adolescents, according to a review in the March issue of The Nurse Practitioner.

26 Jul 2018

People with skin of color experience a variety of skin conditions

Although skin disease can affect anyone, it may not affect everyone in the same way - and this is especially true for patients with skin of color.

26 Jul 2018

Therapy News and Research

Researchers investigate new treatment that is effective against recurrent breast cancers

Researchers discover various mechanisms of resistance to cancer therapy

Researchers discover how breast cells prevent cancer invasion

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

QUT researchers conclude that men do suffer from Postcoital Dysphoria

New study aims to develop nucleoside therapy as treatment for mitochondrial depletion syndromes

Tübingen University Hospital introduces its new Elekta Unity cancer treatment system

Pairing online patient dashboard with 'nudges' to doctors triples statin prescribing rates

New UCI center seeks to empower patients, providers through use of AI in healthcare

OHSU researchers discover disease in monkeys that mimics childhood neurodegenerative disorder

Cannabis appears to have no effect on breathlessness during exercise in advanced COPD patients

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Alnylam’s patisiran receives positive opinion from CHMP for treating hATTR amyloidosis

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

Newer version of ALS drug may effectively treat inherited form of the disease

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

Scientists take important step to understand mechanisms that cause Huntington's disease

Mind-body therapies provide promising approach to tackle teen anxiety

People with skin of color experience a variety of skin conditions

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News